Published in Antioxid Redox Signal on January 10, 2015
Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain. Biomolecules (2016) 0.86
Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality. J Cereb Blood Flow Metab (2015) 0.76
Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain. FASEB J (2017) 0.75
Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke. FASEB J (2017) 0.75
Metabolism of amino-acids: Deamination of amino-acids. Biochem J (1935) 26.23
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Time is brain--quantified. Stroke (2005) 6.96
Accumulation of glutamic acid in isolated brain tissue. Biochem J (1949) 6.56
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci (1999) 5.02
A key role for TRPM7 channels in anoxic neuronal death. Cell (2003) 4.46
Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science (1999) 3.23
Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol (1986) 3.18
Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke (2003) 3.15
Cloning by functional expression of a member of the glutamate receptor family. Nature (1989) 3.11
Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci (2007) 2.89
Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke (2002) 2.87
Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell (2005) 2.63
Calcium, ischemia and excitotoxicity. Cell Calcium (2010) 2.38
Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature (1990) 2.31
A stimulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain. Biochem J (1971) 2.26
Calcium in ischemic cell death. Stroke (1998) 2.19
The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J Neurochem (1972) 2.15
L-glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranes. Nature (1984) 2.10
Glutamate stimulates inositol phosphate formation in striatal neurones. Nature (1985) 2.02
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci (1999) 1.94
Cerebral blood flow and metabolism during cardiopulmonary bypass. Anesth Analg (1993) 1.89
Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J (1990) 1.86
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke (2006) 1.74
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke (1993) 1.72
Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx (2004) 1.71
An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience (1992) 1.70
The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol (1957) 1.67
Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci (2008) 1.62
Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem (2003) 1.61
Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J Biol Chem (2007) 1.57
The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death. Oncogene (2007) 1.55
THE METABOLISM OF GLUTAMATE IN HOMOGENATES AND SLICES OF BRAIN CORTEX. Biochem J (1963) 1.49
Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke (2000) 1.47
Ca2+ signals and neuronal death in brain ischemia. Stroke (2007) 1.45
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med (2001) 1.43
Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab (2001) 1.38
Antagonism of excitatory amino acid-induced responses and of synaptic excitation in the isolated spinal cord of the frog. Br J Pharmacol (1979) 1.36
Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem (2003) 1.33
Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab (2011) 1.31
Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol (2012) 1.25
Calcium antagonists for ischemic stroke: a systematic review. Stroke (2001) 1.24
TRPMs and neuronal cell death. Pflugers Arch (2005) 1.19
The rise and fall of NMDA antagonists for ischemic stroke. Curr Mol Med (2004) 1.16
System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol (2007) 1.15
Chemical excitation of spinal neurones. Nature (1959) 1.14
Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. J Biol Chem (1983) 1.11
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection. J Clin Invest (2014) 1.06
Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke (1995) 1.04
Pathophysiologic cascades in ischemic stroke. Int J Stroke (2012) 1.03
Locations of amino acids in brain slices from the rat. Tetrodotoxin-sensitive release of amino acids. Biochem J (1972) 1.03
Oxygen-sensitive outcomes and gene expression in acute ischemic stroke. J Cereb Blood Flow Metab (2010) 1.00
Real-time visualization of cytoplasmic calpain activation and calcium deregulation in acute glutamate excitotoxicity. J Neurochem (2009) 1.00
Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain. Eur J Neurosci (2001) 0.99
Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Lancet (1997) 0.99
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J Nutr (2012) 0.99
A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke (1991) 0.98
Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia. Neuroscience (2008) 0.98
The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci (2011) 0.97
BMS-204352: a potassium channel opener developed for the treatment of stroke. CNS Drug Rev (2002) 0.96
Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models. Brain Res (2007) 0.95
Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol (2011) 0.94
Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke. Antioxid Redox Signal (2010) 0.94
Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency. J Neurochem (1994) 0.94
Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. Life Sci (1997) 0.93
Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol (2009) 0.93
Minimally invasive neuroradiologic model of preclinical transient middle cerebral artery occlusion in canines. Proc Natl Acad Sci U S A (2008) 0.91
Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid Redox Signal (2011) 0.91
Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab (1994) 0.91
The generation of free radicals by nitric oxide synthase. Comp Biochem Physiol C Toxicol Pharmacol (2003) 0.89
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest (2014) 0.89
Neuroprotection for ischaemic stroke: an unattainable goal? CNS Drugs (2001) 0.89
Glycogen metabolism: metabolic coupling between astrocytes and neurons. Neurology (2010) 0.89
N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann Neurol (1990) 0.88
Ischemic flow threshold for extracellular glutamate increase in cat cortex. J Cereb Blood Flow Metab (1989) 0.87
The 1027th target candidate in stroke: Will NADPH oxidase hold up? Exp Transl Stroke Med (2012) 0.87
Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis. J Cereb Blood Flow Metab (2011) 0.86
The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol (2004) 0.86
Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia. Cell Death Dis (2014) 0.86
The phytoestrogenic isoflavones from Trifolium pratense L. (Red clover) protects human cortical neurons from glutamate toxicity. Phytomedicine (2008) 0.84
Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study. J Cereb Blood Flow Metab (1993) 0.83
Cerebral blood flow thresholds for tissue infarction in patients with acute ischemic stroke treated with intra-arterial revascularization therapy depend on timing of reperfusion. AJNR Am J Neuroradiol (2011) 0.82
Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model. Brain Res (1997) 0.81
The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab (1991) 0.80
Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia. Brain Res (2011) 0.79
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke (1993) 0.79
Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats. Brain Res (2003) 0.78
YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats. Stroke (1998) 0.77
A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats. Brain Res (1998) 0.77
Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke. Cerebrovasc Dis (2000) 0.76
Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats. J Pharmacol Exp Ther (1998) 0.76
A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia. Brain Res (1995) 0.76
Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat in the rat brain. Brain Res (1994) 0.76
Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia. Mol Chem Neuropathol (1997) 0.75
Evaluation of the novel neuroprotective agent BW619C89 in the middle cerebral artery occlusion model of focal ischemia in the spontaneously hypertensive rat and normotensive Fischer 344 rat. Ann N Y Acad Sci (1995) 0.75
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res (2009) 4.88
Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics (2008) 1.57
Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke (2005) 1.56
Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem (2003) 1.40
Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics (2006) 1.31
Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size. J Cereb Blood Flow Metab (2013) 1.08
Tocotrienols: the emerging face of natural vitamin E. Vitam Horm (2007) 1.08
Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. J Neurochem (2009) 1.07
Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann N Y Acad Sci (2008) 1.04
Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J Am Coll Nutr (2010) 1.04
Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr (2004) 1.03
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J Nutr (2012) 0.99
12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys (2007) 0.98
Wound site neutrophil transcriptome in response to psychological stress in young men. Gene Expr (2005) 0.97
Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol (2005) 0.96
Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic Biol Med (2005) 0.95
Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. J Pharmacol Exp Ther (2009) 0.94
Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol (2007) 0.86
An endovascular canine middle cerebral artery occlusion model for the study of leptomeningeal collateral recruitment. Invest Radiol (2011) 0.83
Tocotrienols: the lesser known form of natural vitamin E. Indian J Exp Biol (2011) 0.77
Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food (2015) 0.76